Skip to content

SCHEDULE 13D/AAccepted Jan 16, 6:33 PM ET

Kezar Life Sciences, Inc. SCHEDULE 13D/A

Morningside Venture Investments Ltd

Accepted (ET)

6:33 PM

Jan 16, 2025

Filed

Jan 16, 2025

Documents

7

Size

1.5 MB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.